| Measles virus-based treatments trigger a pro-inflammatory cascade and a distinctive immunopeptidome in glioblastoma S Rajaraman, D Canjuga, M Ghosh, MC Codrea, R Sieger, F Wedekink, ... Molecular Therapy-Oncolytics 12, 147-161, 2019 | 45 | 2019 |
| Targeting CSF1R alone or in combination with PD1 in experimental glioma JM Przystal, H Becker, D Canjuga, F Tsiami, N Anderle, AL Keller, A Pohl, ... Cancers 13 (10), 2400, 2021 | 33 | 2021 |
| Drug repurposing studies of PARP inhibitors as a new therapy for inherited retinal degeneration A Sahaboglu, M Miranda, D Canjuga, M Avci-Adali, N Savytska, E Secer, ... Cellular and Molecular Life Sciences 77, 2199-2216, 2020 | 19 | 2020 |
| Bacterial interactions with proteins and cells relevant to the development of life-threatening endocarditis studied by use of a quartz-crystal microbalance S Krajewski, J Rheinlaender, P Ries, D Canjuga, C Mack, L Scheideler, ... Analytical and Bioanalytical Chemistry 406, 3395-3406, 2014 | 16 | 2014 |
| Homophilic interaction between transmembrane-JAM-A and soluble JAM-A regulates thrombo-inflammation: implications for coronary artery disease D Rath, V Rapp, J Schwartz, S Winter, F Emschermann, D Arnold, ... Basic to Translational Science 7 (5), 445-461, 2022 | 7 | 2022 |
| Argyrin F treatment‐induced vulnerabilities lead to a novel combination therapy in experimental glioma B Walter, D Canjuga, SG Yüz, M Ghosh, P Bozko, JM Przystal, ... Advanced Therapeutics 4 (9), 2100078, 2021 | 7 | 2021 |
| Improving hemocompatibility of artificial lungs by click conjugation of glycoengineered endothelial cells onto blood-contacting surfaces D Canjuga, C Hansen, F Halbrügge, L Hann, S Weiß, C Schlensak, ... Biomaterials Advances 137, 212824, 2022 | 5 | 2022 |
| Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma H Becker, S Castaneda-Vega, K Patzwaldt, JM Przystal, B Walter, ... Brain Sciences 12 (11), 1426, 2022 | 3 | 2022 |
| Experimental glioma with high bHLH expression harbor increased replicative stress and are sensitive toward ATR inhibition MS Koch, S Czemmel, F Lennartz, S Beyeler, S Rajaraman, JM Przystal, ... Neuro-Oncology Advances 2 (1), vdaa115, 2020 | 3 | 2020 |
| P10.04.B LONGITUDINAL [18F ]FET-PET-BASED IMAGING AND PROFILING OF PDGFB-DRIVEN EXPERIMENTAL GLIOMA USING THE RCAS-TVA SYSTEM H Becker, S Castaneda-Vega, K Patzwaldt, JM Przystal, B Walter, ... Neuro-Oncology 25 (Supplement_2), ii62-ii62, 2023 | | 2023 |
| Influence of diet and MOG35-55 peptide preparation on severity, survival, incidence and body weight in murine experimental autoimmune encephalomyelitis M Martorelli, J Laux, M Dengler, T Fischer, D Canjuga, A Vaiceliunaite, ... MULTIPLE SCLEROSIS JOURNAL 28 (3_ SUPPL), 221-221, 2022 | | 2022 |
| Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium D Canjuga, H Steinle, J Mayer, AK Uhde, G Klein, HP Wendel, ... Pharmaceutics 14 (6), 1194, 2022 | | 2022 |
| Multiparametric Longitudinal Profiling of RCAS-tva-Induced PDGFB-Driven Experimental Glioma. Brain Sci. 2022, 12, 1426 H Becker, S Castaneda-Vega, K Patzwaldt, JM Przystal, B Walter, ... Pathogenesis Study of Glioma, 21, 2022 | | 2022 |
| Homing of mRNA-Modified Endothelial Progenitor Cells to Inflamed Endothelium. Pharmaceutics 2022, 14, 1194 D Canjuga, H Steinle, J Mayer, AK Uhde, G Klein, HP Wendel, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2022 | | 2022 |
| EXTH-48. NOVEL COMBINATION THERAPY IN PRECLINICAL GLIOMA MODELS USING THE CELL CYCLE STABILIZING COMPOUND ARGYRIN F AND CHECKPOINT INHIBITION B Walter, D Canjuga, SG Yuez, M Ghosh, P Bozko, J Przystal, ... Neuro-Oncology 23 (Supplement_6), vi174-vi174, 2021 | | 2021 |
| TAMI-34. TARGETING CSF1R AND PD1 IN EXPERIMENTAL GLIOMA H Becker, JM Przystal, D Canjuga, F Tsiami, N Anderle, AL Keller, A Pohl, ... Neuro-Oncology 23 (Supplement_6), vi205-vi205, 2021 | | 2021 |
| Inhibiting BHLH Transcriptional Networks Using Dominant Negative E47 Leads to a Strong Anti-Glioma Activity in Vitro and in Vivo M Koch, S Czemmel, F Lennartz, S Beyeler, J Pryztal, P Govindarajan, ... ONCOLOGY RESEARCH AND TREATMENT 43, 37-37, 2020 | | 2020 |
| Argyrin F Leads to Targetable Treatment-Induced Vulnerabilities in Experimental Glioma B Walter, D Canjuga, M Ghosh, SC Beck, P Bozko, S Stevanovic, N Malek, ... ONCOLOGY RESEARCH AND TREATMENT 43, 36-36, 2020 | | 2020 |
| Targeting of CSF1R and PD1 in Experimental Glioma JM Przystal, H Becker, D Canjuga, CH Ries, M Schtmittnaegel, ... ONCOLOGY RESEARCH AND TREATMENT 43, 35-36, 2020 | | 2020 |
| Neuro-Oncology Advances MS Koch, S Czemmel, F Lennartz, S Beyeler, S Rajaraman, JM Przystal, ... | | 2020 |
Justyna Magdalena Przystal, PhDUniversity Children's Hospital ZurichVerified email at alumni.imperial.ac.uk
